Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

Share Price is delayed by 15 minutes
Get Live Data
4,599.00    48.00 (1.05%)
Bid:
4,593.00
Ask:
4,594.00
Spread: 1.00 (0.022%)
Market Cap: £99.03b
ULVR Live PriceLast checked at - London Stock Exchange

Intraday Unilever Share Chart

Directorate Change

31 Jan 2024 15:00

RNS Number : 5724B
Unilever PLC
31 January 2024
 

Unilever PLCUnilever Board Update

 

Unilever today announced that Judith McKenna has been appointed as an independent Non-Executive Director. Judith will join the Unilever Board with effect from 1 March 2024.

 

Judith has deep and extensive experience of the consumer goods and retail sector, having spent 27 years of her career at Walmart. She most recently served as President and CEO of Walmart International from 2018-2023, where she was responsible for all aspects of Walmart's footprint outside the U.S.

 

Prior to leading Wal-Mart International, Judith served as Executive Vice President and Chief Operating Officer for Wal-Mart U.S. and was the Chief Financial Officer for the supermarket chain Asda, in the UK, for more than a decade.(1)

 

Unilever today also announced that the following Non-Executive Directors will offer themselves for election or re-election to the Unilever PLC Board at the Annual General Meeting of Unilever PLC on 1 May 2024 (the "2024 AGM"): Ian Meakins (Chair of the Board), Adrian Hennah, Andrea Jung, Ruby Lu, Susan Kilsby, Nelson Peltz and Judith McKenna.

 

Hein Schumacher, CEO, and Fernando Fernandez, CFO, will also offer themselves for re-election and election, respectively, to the Unilever PLC Board at the 2024 AGM.

 

Non-Executive Directors Nils Andersen, Judith Hartmann, Youngme Moon and Strive Masiyiwa have decided not to stand for re-election at the 2024 AGM.

 

Unilever Chair Ian Meakins said: "On behalf of the Board, I would like to thank Nils Andersen, Judith Hartmann, Youngme Moon and Strive Masiyiwa for their contribution to the Unilever PLC Board over their many years of service. I would also like to welcome Judith McKenna to the Board. Judith brings a wealth of experience in the consumer and retail sector, and I am sure we will greatly benefit from her experience and expertise."

 

There are no other matters that require disclosure under 9.6.13R of the UK Listing Rules.

 

 

(1) Judith has in the past 5 years previously been the Chair of Walmex, a Bolsa-listed company, and a board member of Flipkart and PhonePe in India. She is no longer a director of those companies.

 

Enquiries

 

Media: pressoffice.london@unilever.com

Lucila Zambrano +44 7825 273 767 / lucila.zambrano@unilever.com 

 

Investors:

Investor Relations Team +44 20 7822 6830 

investor.relations@unilever.com 

 

 -ends-

  

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABBMJTMTIJBII
Date   Source Headline
16th Aug 20247:00 amRNSTransaction in Own Shares
15th Aug 20247:00 amRNSTransaction in Own Shares
14th Aug 202412:57 pmRNSDirector/PDMR Shareholding
14th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20247:00 amRNSTransaction in Own Shares
12th Aug 20247:00 amRNSTransaction in Own Shares
9th Aug 20247:00 amRNSTransaction in Own Shares
8th Aug 20247:00 amRNSTransaction in Own Shares
7th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSTransaction in Own Shares
5th Aug 20247:00 amRNSTransaction in Own Shares
2nd Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20242:10 pmRNSTotal Voting Rights
1st Aug 20247:00 amRNSTransaction in Own Shares
31st Jul 20247:00 amRNSTransaction in Own Shares
30th Jul 20247:00 amRNSTransaction in Own Shares
29th Jul 20247:00 amRNSTransaction in Own Shares
26th Jul 20245:59 pmRNSPUBLICATION OF SUPPLEMENT
26th Jul 20247:00 amRNSTransaction in Own Shares
25th Jul 20247:00 amRNS2024 First Half Results
25th Jul 20247:00 amRNSTransaction in Own Shares
24th Jul 20247:00 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSTransaction in Own Shares
22nd Jul 20247:00 amRNSTransaction in Own Shares
19th Jul 20244:44 pmRNSAppointment of NED
19th Jul 202410:36 amRNSTransaction in Own Shares
18th Jul 20247:00 amRNSTransaction in Own Shares
17th Jul 20247:00 amRNSTransaction in Own Shares
16th Jul 20247:00 amRNSTransaction in Own Shares
15th Jul 20247:00 amRNSTransaction in Own Shares
12th Jul 20247:00 amRNSTransaction in Own Shares
11th Jul 20247:00 amRNSTransaction in Own Shares
10th Jul 20247:00 amRNSTransaction in Own Shares
9th Jul 20247:00 amRNSTransaction in Own Shares
8th Jul 20247:00 amRNSTransaction in Own Shares
5th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 20247:00 amRNSTransaction in Own Shares
3rd Jul 20247:00 amRNSTransaction in Own Shares
2nd Jul 20247:00 amRNSTransaction in Own Shares
1st Jul 202411:33 amRNSBlock listing Interim Review
1st Jul 202411:33 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTransaction in Own Shares
28th Jun 20247:00 amRNSTransaction in Own Shares
27th Jun 20247:00 amRNSTransaction in Own Shares
26th Jun 20247:00 amRNSTransaction in Own Shares
25th Jun 20247:00 amRNSTransaction in Own Shares
24th Jun 20247:00 amRNSTransaction in Own Shares
21st Jun 20247:00 amRNSTransaction in Own Shares
20th Jun 20247:00 amRNSTransaction in Own Shares
19th Jun 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.